BLINCYTO Powder for concentrate for solution for infusion
Country: Saudi Arabia
Language: English
Source: SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
BLINATUMOMAB
Available from:
Amgen Inc., United States
ATC code:
L01XC
INN (International Name):
BLINATUMOMAB
Dosage:
35 µg
Pharmaceutical form:
Powder for concentrate for solution for infusion
Administration route:
Intravenous use
Units in package:
1 Vial
Class:
Biological
Prescription type:
Prescription
Manufactured by:
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
Product summary:
Agent: Salehiya Trading Co.; Price: 9946.20; Storage conditions: store in a refrigerator (2°c – 8°c); Shelf life: 60; Description code: 7000000158-35-100000074029; Distribution area: Hospital
Authorization status:
Marketed; Valid
Authorization date:
2017-01-01
